Development

A pharma giant pays $2.75B for AI-developed drugs

development2026-03-31

Claim

Eli Lilly struck a $2.75 billion deal with Insilico to bring AI-developed drugs to global markets, while the University of Michigan built a bismuth selenide memristor combining long-term retention with analog tuning.

Reported metric: $2.75B

Reporting date: 2026-03-31 (not necessarily the event date)

Sources

Attribution and reporting linked by this record; links do not imply independent verification.

Welcome to March 31, 2026 (theinnermostloop.substack.com)

Knowledge graphopen in browser →

Reported in

Welcome to March 31, 2026

Actor

Evidence for

Supersedes

A desktop mode ships for biology, from phylogeny to CRISPR screens

Referenced by

Cite or correct this record

Citation formatCitation text

A pharma giant pays $2.75B for AI-developed drugs
Innermost Loop KB — secondary record
Reporting date: 2026-03-31
KB permalink: https://nicholsn.github.io/innermost-loop-kb/developments/2026-03-31-lilly-insilico-275b
Claim: Eli Lilly struck a $2.75 billion deal with Insilico to bring AI-developed drugs to global markets, while the University of Michigan built a bismuth selenide memristor combining long-term retention with analog tuning.
Attributed sources:
- Welcome to March 31, 2026 — https://theinnermostloop.substack.com/p/welcome-to-march-31-2026
This citation does not imply independent verification of linked-source claims.

Suggest a correction — opens a GitHub draft for you to review and submit.